Found 12 matching trials
Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist PHASE3 To evaluate the safety and efficacy of two dose ranges of safinamide (High ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease PHASE3 The purpose of this study is to evaluate the efficacy and safety of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa PHASE3 This is a Phase III, multicentre, randomised, double-blind, placebo-control...
Show More Location
Sir Run Run Shaw Hospital, Zhejiang University 浙江大学医学院附属邵逸夫医院
Learn More & Join Trial
Effect of Safinamide on Parkinson's Disease Related Chronic Pain PHASE4 Primary objective:
• To evaluate the potential efficacy of safinamide 100 ...
Show More Location
Medizinische Universitat Innsbruck
Learn More & Join Trial
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD PHASE3 The purpose of this study is to determine the long-term efficacy and safety...
Show More Location
Multiple Locations
Learn More & Join Trial
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa PHASE3 Parkinson's Disease is a major neurodegenerative disorder in which there is...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension) PHASE3 To determine the long-term safety and efficacy of a dose range of safinamid...
Show More Location
Multiple Locations
Learn More & Join Trial
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist PHASE3 Parkinson's disease is a major neurodegenerative disorder in which there is...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918) PHASE3 Parkinson's disease is a major neurodegenerative disorder in which there is...
Show More Location
Enquire Central Contact
Learn More & Join Trial
Safinamide for Multiple System Atrophy (MSA) PHASE2 The study is a placebo controlled study, with two parallel arms, in which p...
Show More Location
Università di Bologna
Learn More & Join Trial